Improving mitochondrial bioenergetics under ischemic conditions increases warm ischemia tolerance in the kidney

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 1, 2015, Pages F11-F21

  Szeto, Hazel H ^a   Liu, Shaoyi ^a   Soong, Y ^a   Birk, Alexander V ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Acute kidney injury; Chronic kidney disease; Ischemia reperfusion injury; Mitochondrial cristae; Mitochondrial swelling; SS 20; Szeto Schiller peptides

Indexed keywords

BETA1 INTEGRIN; PEPTIDE DERIVATIVE; SODIUM CHLORIDE; SS 20; UNCLASSIFIED DRUG; UVOMORULIN; ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SYNTHETIC PEPTIDE; TETRAPEPTIDE; URINARY TRACT AGENT; OLIGOPEPTIDE; PHENYLALANYL-ARGINYL-PHENYLALANYLLYSINAMIDE;

ACTIN FILAMENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CELL DENSITY; CELL SWELLING; CONTROLLED STUDY; HEAT TOLERANCE; ISOLATED KIDNEY; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; KIDNEY TUBULE; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; RESPIRATORY CHAIN; TRANSMISSION ELECTRON MICROSCOPY; ACUTE KIDNEY FAILURE; BRUSH BORDER; CYTOSKELETON; HISTOLOGY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; RESPIRATION CONTROL; UREA NITROGEN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; DRUG SCREENING; ISCHEMIA; KIDNEY; METABOLISM; RANDOMIZATION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DRUG EVALUATION, PRECLINICAL; KIDNEY; MALE; MITOCHONDRIA; OLIGOPEPTIDES; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; WARM ISCHEMIA;

EID: 84928635881     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00366.2014     Document Type: Article

References (59)

1. Aluri HS, Simpson DC, Allegood JC, Hu Y, Szczepanek K, Gronert S, Chen Q, Lesnefsky EJ. Electron flow into cytochrome c coupled with reactive oxygen species from the electron transport chain converts cytochrome c to a cardiolipin peroxidase: role during ischemia-reperfusion. Biochim Biophys Acta 1840: 3199–3207, 2014.
2. Anderson SE, Dickinson CZ, Liu H, Cala PM. Effects of Na-K-2Cl cotransport inhibition on myocardial Na and Ca during ischemia and reperfusion. Am J Physiol Cell Physiol 270: C608–C618, 1996.
3. Atkinson SJ, Hosford MA, Molitoris BA. Mechanism of actin polymerization in cellular ATP depletion. J Biol Chem 279: 5194–5199, 2004.
4. Basova LV, Kurnikov IV, Wang L, Ritov VB, Belikova NA, Vlasova II, Pacheco AA, Winnica DE, Peterson J, Bayir H, Waldeck DH, Kagan VE. Cardiolipin switch in mitochondria: shutting off the reduction of cytochrome c and turning on the peroxidase activity. Biochemistry 46: 3423–3434, 2007.
5. Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi F, Russo P, Stockle M. Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol 56: 625–634, 2009.
6. Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 171: 2017–2028, 2014.
7. Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, Seshan SV, Pardee JD, Szeto HH. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol 24: 1250–1261, 2013.
8. Brezis M, Rosen S, Silva P, Epstein FH. Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated perfused rat kidney. J Clin Invest 73: 182–190, 1984.
9. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG. Guideline for management of the clinical T1 renal mass. J Urol 182: 1271–1279, 2009.
10. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294: C460–C466, 2008.
11. Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, Hong MK. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 18: 215–220, 2007.
12. Eirin A, Ebrahimi B, Zhang X, Zhu XY, Woollard JR, He Q, Textor SC, Lerman A, Lerman LO. Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease. Cardiovasc Res 103: 461–472, 2014.
13. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 60: 1242–1249, 2012.
14. Evans RG, Gardiner BS, Smith DW, O’Connor PM. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 295: F1259–F1270, 2008.
15. Halestrap AP. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38: 841–860, 2010.
16. Hall AM, Rhodes GJ, Sandoval RM, Corridon PR, Molitoris BA. In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury. Kidney Int 83: 72–83, 2013.
17. Hall AM, Unwin RJ, Parker N, Duchen MR. Multiphoton imaging reveals differences in mitochondrial function between nephron segments. J Am Soc Nephrol 20: 1293–1302, 2009.
18. Hanske J, Toffey JR, Morenz AM, Bonilla AJ, Schiavoni KH, Pletneva EV. Conformational properties of cardiolipin-bound cytochrome c. Proc Natl Acad Sci USA 109: 125–130, 2012.
19. Iwai T, Tanonaka K, Inoue R, Kasahara S, Kamo N, Takeo S. Mitochondrial damage during ischemia determines postischemic contractile dysfunction in perfused rat heart. J Mol Cell Cardiol 34: 725–738, 2002.
20. Iwai T, Tanonaka K, Inoue R, Kasahara S, Motegi K, Nagaya S, Takeo S. Sodium accumulation during ischemia induces mitochondrial damage in perfused rat hearts. Cardiovasc Res 55: 141–149, 2002.
21. Kaasik A, Safiulina D, Zharkovsky A, Veksler V. Regulation of mitochondrial matrix volume. Am J Physiol Cell Physiol 292: C157–C163, 2007.
22. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223–232, 2005.
23. Karam JA, Wood CG. The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated? Eur Urol 62: 136–139, 2012.
24. Katz AI. Distribution and function of classes of ATPases along the nephron. Kidney Int 29: 21–31, 1986.
25. Kiebish MA, Yang K, Sims HF, Jenkins CM, Liu X, Mancuso DJ, Zhao Z, Guan S, Abendschein DR, Han X, Gross RW. Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency. J Biol Chem 287: 25086–25097, 2012.
26. Kiil F, Aukland K, Refsum HE. Renal sodium transport and oxygen consumption. Am J Physiol 201: 511–516, 1961.
27. Kim SP, Murad MH, Thompson RH, Boorjian SA, Weight CJ, Han LC, Erwin PJ, Costello BA, Chow GK, Leibovich BC. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 188: 51–57, 2012.
28. Kleber AG. Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res 52: 442–450, 1983.
29. Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, Gorman JH, Sloan RC, Frasier CR, Watson CA, Bostian PA, Kypson AP, Brown DA. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc 1: e001644, 2012.
30. Lassen NA, Munck O, Thaysen JH. Oxygen consumption and sodium reabsorption in the kidney. Acta Physiol Scand 51: 371–384, 1961.
31. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tandler B, Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258–H267, 2004.
32. Levraut J, Iwase H, Shao ZH, Vanden Hoek TL, Schumacker PT. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 284: H549–H558, 2003.
33. Liu S, Soong Y, Seshan SV, Szeto HH. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis. Am J Physiol Renal Physiol 306: F970–F980, 2014.
34. Mandel LJ. Primary active sodium transport, oxygen consumption, and ATP: coupling and regulation. Kidney Int 29: 3–9, 1986.
35. Molitoris BA. Na_-K_-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol Renal Fluid Electrolyte Physiol 265: F693–F697, 1993.
36. Osman C, Voelker DR, Langer T. Making heads or tails of phospholipids in mitochondria. J Cell Biol 192: 7–16, 2011.
37. Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M, Devarajan P, Venkatachalam MA. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol 24: 506–517, 2013.
38. Patel AR, Eggener SE. Warm ischemia less than 30 minutes is not necessarily safe during partial nephrectomy: every minute matters. Urol Oncol 29: 826–828, 2011.
39. Pegg DE. Organ preservation. Surg Clin North Am 66: 617–632, 1986.
40. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278: 52873–52880, 2003.
41. Santucci R, Ascoli F. The Soret circular dichroism spectrum as a probe for the heme Fe(III)-Met(80) axial bond in horse cytochrome c. J Inorg Biochem 68: 211–214, 1997.
42. Scalettar BA, Abney JR, Hackenbrock CR. Dynamics, structure, and function are coupled in the mitochondrial matrix. Proc Natl Acad Sci USA 88: 8057–8061, 1991.
43. Schley G, Klanke B, Schodel J, Forstreuter F, Shukla D, Kurtz A, Amann K, Wiesener MS, Rosen S, Eckardt KU, Maxwell PH, Willam C. Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J Am Soc Nephrol 22: 2004–2015, 2011.
44. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189–200, 2011.
45. Siegel NJ, Avison MJ, Reilly HF, Alger JR, Shulman RG. Enhanced recovery of renal ATP with postischemic infusion of ATP-MgCl2 determined by 31P-NMR. Am J Physiol Renal Fluid Electrolyte Physiol 245: F530–F534, 1983.
46. Sinibaldi F, Droghetti E, Polticelli F, Piro MC, Di Pierro D, Ferri T, Smulevich G, Santucci R. The effects of ATP and sodium chloride on the cytochrome c-cardiolipin interaction: the contrasting behavior of the horse heart and yeast proteins. J Inorg Biochem 105: 1365–1372, 2011.
47. Sinibaldi F, Fiorucci L, Patriarca A, Lauceri R, Ferri T, Coletta M, Santucci R. Insights into cytochrome c-cardiolipin interaction. Role played by ionic strength. Biochemistry 47: 6928–6935, 2008.
48. Snider EJ, Muenzner J, Toffey JR, Hong Y, Pletneva EV. Multifaceted effects of ATP on cardiolipin-bound cytochrome c. Biochemistry 52: 993–995, 2013.
49. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 171: 2029–2050, 2014.
50. Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemiareperfusion injury. Antioxid Redox Signal 10: 601–619, 2008.
51. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22: 1041–1052, 2011.
52. Szeto HH, Schiller PW. Novel therapies targeting inner mitochondrial membrane–from discovery to clinical development. Pharm Res 28: 2669–2679, 2011.
53. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 58: 340–345, 2010.
54. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 79: 356–360, 2012.
55. Uchida S, Endou H. Substrate specificity to maintain cellular ATP along the mouse nephron. Am J Physiol Renal Fluid Electrolyte Physiol 255: F977–F983, 1988.
56. Zhang M, Mileykovskaya E, Dowhan W. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277: 43553–43556, 2002.
57. Zhao K, Luo G, Giannelli S, Szeto HH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol 70: 1796–1806, 2005.
58. Zhao K, Luo G, Zhao GM, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3_ net charge opioid tetrapeptide. J Pharmacol Exp Ther 304: 425–432, 2003.
59. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279: 34682–34690, 2004.